|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Apr―26 |
Utilization of clinical practice guidelines for cancer care in routine practice and during the coronavirus disease 2019 pandemic in India |
Prashant Mathur, Thilagavathi Ramamoorthy, Sudarshan Kondalli Lakshminarayana, Anita Nath, Stany Mathew, Gurpreet Kaur Rajput |
2 |
[GO] |
2024―Feb―23 |
Colorectal cancer treatment outcomes during the pandemic: Our experience of COVID-19 at a tertiary referral center |
Christy Kei, Richard Gartrell, Yasser Arafat, Elizabeth Degabriele, Josephine Yeung, Steven Chan, et al. (+2) Ian Faragher, Justin M. C. Yeung |
3 |
[GO] |
2024―Jan―15 |
Response to COVID-19 vaccination in patients on cancer therapy: Analysis in a SARS-CoV-2-naïve population |
George Cavic, Andrew A. Almonte, Sarah M. Hicks, Teresa Neeman, Jo-Wai Wang, Sue Brew, et al. (+6) Philip Y. Choi, Ian Cockburn, Elizabeth E. Gardiner, Desmond Yip, Aude M. Fahrer, Yada Kanjanapan |
4 |
[GO] |
2023―Apr―07 |
Comparison of antibody response to coronavirus disease 2019 vaccination between patients with solid or hematologic cancer patients undergoing chemotherapy |
Sung Hee Lim, Seong Hyeok Choi, Young Sok Ji, Se Hyung Kim, Chan Kyu Kim, Jina Yun, Seong Kyu Park |
5 |
[GO] |
2023―Jan―26 |
Functional results and feasibility of a teleprehabilitation program in patients who are candidates for elective colorectal cancer surgery during the COVID-19 pandemic |
Luz Alejandra Lorca, Ivana Leao Ribeiro, Marta Pizarro, Mónica Martínez, Jessica Vivallos |
6 |
[GO] |
2022―Okt―25 |
The impact of coronavirus disease 2019 on genitourinary and prostate cancer care and clinical trials: A qualitative exploration of the Australian and New Zealand experience |
Natasha A. Roberts, Haryana M. Dhillon, Catherine Paterson, Kathryn Schubach, Margaret McJannett |
7 |
[GO] |
2022―Jul―19 |
Experiences and perspectives of cancer stakeholders regarding COVID-19 vaccination |
Nicci Bartley, Polly Havard, Phyllis Butow, Joanne Shaw |
8 |
[GO] |
2022―Jan―19 |
COVID-19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter study |
Mike Nguyen, Nathan Bain, Lisa Grech, Tammie Choi, Sam Harris, Hieu Chau, et al. (+7) Daniel Freeman, Alastair Kwok, Janne Williams, Amelia McCartney, Kate Webber, Daphne Day, Eva Segelov |
9 |
[GO] |
2021―Nov―29 |
Dilemma and solutions of treatment delay in cancer patients during the COVID-19 pandemic: A single-center, prospective survey |
Yan'e Liu, Yanhong Yao, Qiqi Wang, Zhentao Liu, Yangchun Gu, Hua Zhang, et al. (+2) Fumei Yi, Baoshan Cao |
10 |
[GO] |
2021―Jul―22 |
Improving regional access: Phase 1 teletrials in the era of COVID-19 |
Gregory Gaughran, John Zalcberg, Cheryl-Ann Hawkins, Mark Shackleton, Mark Voskoboynik |
11 |
[GO] |
2021―Apr―16 |
Prostate cancer management in the era of COVID-19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro-oncology |
Darren Ming-Chun Poon, Chi-Kwok Chan, Tim-Wai Chan, Foon-Yiu Cheung, Lap-Yin Ho, Philip Wai-Kay Kwong, et al. (+6) Eric Ka-Chai Lee, Angus Kwong-Chuen Leung, Simon Yiu-Lam Leung, Hing-Shing So, Po Chor Tam, Wai-Kit Ma |
12 |
[GO] |
2021―Apr―05 |
Resilience and ongoing quality care for cancer clinical trials during COVID-19: Experience from a tertiary hospital in Australia |
Amy Ives, Tricia Pusztai, Jacqui Keller, Elizabeth Ahern, Bryan Chan, Harry Gasper, et al. (+5) David Wyld, Glen Kennedy, Graeme Dickie, Zarnie Lwin, Natasha A. Roberts |
13 |
[GO] |
2021―Feb―21 |
Clinical features and prognosis of patients with COVID-19 after lung surgery: A retrospective clinical study |
Jie Bai, Hongling Chu, Shaohua Ma, Qinggang Ge |
14 |
[GO] |
2021―Feb―11 |
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic |
Koen Degeling, Nancy N. Baxter, Jon Emery, Mark A. Jenkins, Fanny Franchini, Peter Gibbs, et al. (+4) G. Bruce Mann, Grant McArthur, Benjamin J. Solomon, Maarten J. IJzerman |
15 |
[GO] |
2021―Jan―27 |
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium |
Toshio Shimizu, Dong-Wan Kim, Herbert H. Loong, Chia-Chi Lin, Matthew CH Ng, Noboru Yamamoto, et al. (+2) Brigette Ma, Daniel SW Tan |
16 |
[GO] |
2020―Okt―20 |
Covid-19: What is the best approach in gynecological oncology patient management during the coronavirus pandemic? |
Malihe Hasanzadeh, Afrooz Azad, Marjaneh Farazestanian, Leila Mousavi Seresht |
17 |
[GO] |
2020―Sep―24 |
Impact of COVID-19 on cancer patients: A review |
Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares |
18 |
[GO] |
2020―Sep―09 |
Radiation oncology during COVID-19: Strategies to avoid compromised care |
Patrick J Horsley, Michael Back, Gillian Lamoury, Brian Porter, Jeremy Booth, Thomas N Eade |
19 |
[GO] |
2020―Apr―20 |
Strategies for patient with cancer during COVID-19 pandemic |
Zhenzhen Zhao, Chao Yang, Changchun Li |